Serine/Arginine-Rich Splicing Factor 1 (SRSF1) Is Required for Adult and Embryonic Hematopoiesis and Has Non-Overlapping Roles with SRSF2 in Hematopoiesis

被引：0
|
作者：
Chung, Young Rock [1 ]
Cho, Hana [2 ]
Kim, Young Joon [2 ]
Kim, Eunhee [3 ]
Lee, Stanley Chun-Wei [2 ]
Abdel-Wahab, Omar [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Ulsan Natl Inst Sci & Technol, Dept Biol Sci, Ulsan, South Korea
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1478.1478
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1478
引用
收藏
页数：6
相关论文
共 38 条
  • [21] Serine Arginine/Rich Splicing Factor 1 (SRSF1) Increases IL-2 Production in T Cells By Increasing the Expression of NFAT and c-Fos
    Katsuyama, Takayuki
    Mosho, Michael W.
    Tsokos, George C.
    Moulton, Vaishali R.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [22] Serine/Arginine-Rich Splicing Factor 1 (SRSF1) Is a Novel Regulator of T Cell Function and Its Selective Deficiency in T Lymphocytes Leads to Autoimmunity and Lupus-like Nephritis
    Moulton, Vaishali R.
    Katsuyama, Takayuki
    Li, Hao
    Mosho, Michael W.
    Gillooly, Andrew R.
    Tsokos, George C.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [23] Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma
    Gout, Stephanie
    Brambilla, Elisabeth
    Boudria, Asma
    Drissi, Romain
    Lantuejoul, Sylvie
    Gazzeri, Sylvie
    Eymin, Beatrice
    [J]. PLOS ONE, 2012, 7 (10):
  • [24] Molecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells
    Michael Craigie
    Patrick Regan
    Yolanda-Lopez Otalora
    Ilker Kudret Sariyer
    [J]. Virology Journal, 12
  • [25] Molecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells
    Craigie, Michael
    Regan, Patrick
    Otalora, Yolanda-Lopez
    Sariyer, Ilker Kudret
    [J]. VIROLOGY JOURNAL, 2015, 12
  • [26] Serine/arginine splicing factor 1 (SRSF1) mediates DNA repair and chemo-sensitivity and drives growth in small cell lung cancer
    Conley, Sarah J.
    Yao, Xin
    Huang, Jiaqi
    Higgs, Brandon
    Hu, Zhibin
    Xiao, Zhan
    Zhong, Haihong
    Liu, Zheng
    Brohawn, Philip
    Ge, Xiaoxiao
    Czapiga, Meggan
    Oganesyan, Vaheh
    Fu, Haihua
    Tice, David
    Herbst, Ronald
    Su, Xinying
    Gu, Yi
    Gu, Jianren
    Han, Baohui
    Richman, Laura
    Jallal, Bahija
    Jiang, Liyan
    Shen, Hongbing
    Yao, Yihong
    [J]. CANCER RESEARCH, 2015, 75
  • [27] Activation-induced cytidine deaminase (AID)-dependent somatic hypermutation requires a splice isoform of the serine/arginine-rich (SR) protein SRSF1
    Kanehiro, Yuichi
    Todo, Kagefumi
    Negishi, Misaki
    Fukuoka, Junji
    Gan, Wenjian
    Hikasa, Takuya
    Kaga, Yoshiaki
    Takemoto, Masayuki
    Magari, Masaki
    Li, Xialu
    Manley, James L.
    Ohmori, Hitoshi
    Kanayama, Naoki
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (04) : 1216 - 1221
  • [28] Decreased Levels of SRSF1 (Serin/Arginine-Rich Splicing Factor1) Induced Lower Levels of RasGRP1 in T Cells from Patients with Systemic Lupus Erythematosus.
    Kurita, Takashi
    Yasuda, Shinsuke
    Moulton, Vaishali
    Shimizu, Yuka
    Kono, Michihito
    Koide, Hideyuki
    Oku, Kenji
    Bohgaki, Toshiyuki
    Amengual, Olga
    Horita, Tetsuya
    Tsokos, George C.
    Atsumi, Tatsuya
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1171 - S1171
  • [29] Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion
    Wahid, Mussarat
    Pratoomthai, Benjamart
    Egbuniwe, Isioma U.
    Evans, Hannah R.
    Babaei-Jadidi, Roya
    Amartey, Jason O.
    Erdelyi, Viola
    Yacqub-Usman, Kiren
    Jackson, Andrew M.
    Morris, Jonathan C.
    Patel, Poulam M.
    Bates, David O.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (12) : 4001 - 4014
  • [30] Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion
    Mussarat Wahid
    Benjamart Pratoomthai
    Isioma U. Egbuniwe
    Hannah R. Evans
    Roya Babaei-Jadidi
    Jason O. Amartey
    Viola Erdelyi
    Kiren Yacqub-Usman
    Andrew M. Jackson
    Jonathan C. Morris
    Poulam M. Patel
    David O. Bates
    [J]. Cancer Immunology, Immunotherapy, 2023, 72 : 4001 - 4014
1234